Perspectives: Hold on Tight for the Ride
A crazy, mixed-up world of cell & gene therapy in 2023 News concerning cell and gene therapy (CGT) may make you feel like you are on a...
Connect With Aldevron
Stay informed on Aldevron events, product updates, company news and industry outlooks with our blog, news articles and email newsletters. Sign up today!
- Blog Posts and News Updates
The latest thought leadership discussions and news articles from Aldevron - Company Email Updates
A monthly summary of company news, product notifications and event schedules
Latest Blogs
An evolution at TIDES
mRNA joins the mix In the past, the TIDES USA conference event has been focused on oligonucleotide and peptide therapeutics, providing information on...
When Demand Gets Tough, Expansion Gets Going
Ongoing growth in CGT capacity As the era of genomic medicine gains speed with the innovation of new technologies, we are at the forefront of genetic...
Latest News
Aldevron Announces Expansion of mRNA Production Capability
Will offer mRNA cGMP Production from Master Cell Bank to Drug Product Made Possible with Precision Nanosystems and Cytiva Aldevron, a leading global...
Aldevron Launches Eureca-V™ MAD7®, a Type-V CRISPR Nuclease
Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, launches Eureca-V™...
Webinar: How a Sponsored CMC Platform Accelerates mRNA Projects to the Clinic
On the pathway to GMP manufacturing in support of clinical trials, multiple technology transfers may correlate to an increase in complexity and risk...